Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

OBJECTIVE: To investigate whether baseline CSF biomarkers are associated with hippocampal atrophy rate as a measure of disease progression in patients with Alzheimer disease (AD), patients with mild cognitive impairment (MCI), and controls, controlling for baseline neuropsychological and MRI finding...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Henneman, W J.P., Vrenken, H, Barnes, J, Sluimer, I C., Verwey, N A., Blankenstein, M A., Klein, M, Fox, N C., Scheltens, P, Barkhof, F, van der Flier, W M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Academy of Neurology 2009
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2839552/
https://ncbi.nlm.nih.gov/pubmed/19770469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181b879ac
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados